HTGM - HTGモレキュラ―・ダイアグノスティックス （HTG Molecular Diagnostics Inc.） HTGモレキュラ―・ダイアグノスティックスHTGMのチャート
HTGMの企業情報
| symbol | HTGM |
|---|---|
| 会社名 | HTG Molecular Diagnostics Inc （HTGモレキュラ―・ダイアグノスティックス） |
| 分野（sector） | Capital Goods 資本財（工業製品） |
| 産業（industry） | Biotechnology: Laboratory Analytical Instruments |
| 業種 | 先端医療機器_テクノロジ― 医療関連（Health Care） |
| 概要 | 事業概要 HTG・モレキュラー・ダイアグノスティックス（HTG Molecular Diagnostics Inc）はトランスレーショナルリサーチ・医学及び分子診断学ためmRNA測定、及びマイクロRNA（miRNA）ため製品の提供に従事する米国の会社である。同社の定量的ヌクレアーゼプロテクションアッセイ（ｑＮＰＡ）分子技術プラットフォームは、特にホルマリン固定パラフィン包埋（FFPE）組織及びその他生物サンプル種類から、遺伝子発現レベルの変化を検出するのに適している。製品は「HTG」エッジシステム、「HTG」エッジアッセイ及び「HTG」アッセイダイレクトを含む。「HTG」エッジシステムは24時間未満で、生物学的サンプル（組織、血液、血清、細胞）の多数の抽出フリー・多重化結果を提供する自動化RNA解析プラットフォームである。「HTG」エッジDMPKアッセイは、研究者の前臨床試験における薬物代謝の特徴づけを可能にする47遺伝子アッセイである。「HTG」エッジトップオンコジーンアッセイは新鮮又は固定生物試料において32の最も一般的に検定した癌遺伝子の発現レベルの測定を行う。 HTGモレキュラ―・ダイアグノスティックスは米国の医療関連診断システムメ―カ―。複雑な分子プロファイリングの日常的な使用を容易にするための新たな技術プラットフォ―ムの開発、販売に従事。主要製品として、計装、消耗品、ソフトウェア解析から成るHTGエッジプラットフォ―ムを提供し、遺伝子および遺伝子活性の分子プロファイリングの自動化を実現する。 about htg molecular diagnostics: headquartered in tucson, arizona, htg's mission is to empower precision medicine at the local level. in 2013 the company commercialized its htg edge instrument platform and a portfolio of rna assays that leverage htg's proprietary nuclease protection chemistry. htg's product offerings have since expanded to include its htg edgeseq product line, which automates sample and targeted library preparation for next-generation sequencing. additional information is available at www.htgmolecular.com. |
| 本社所在地 | 3430 E. Global Loop Tucson AZ 85706 USA |
| 代表者氏名 | Ann F. Hanham アンF.ハナム |
| 代表者役職名 | Independent Chairman of the Board |
| 電話番号 | ― |
| 設立年月日 | 35704 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | 2015年 |
| 従業員数 | － |
| url | www.htgmolecular.com |
| nasdaq_url | https://www.nasdaq.com/symbol/htgm |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -14.64091 |
| 終値（lastsale） | 3.955 |
| 時価総額（marketcap） | 112407867.005 |
| 時価総額 | 時価総額（百万ドル） 100.61290 |
| 売上高 | 売上高（百万ドル） 20.69706 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 77.05323 |
| 当期純利益 | 当期純利益（百万ドル） -16.78553 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 HTG Molecular Diagnostics Inc revenues increased from $3.1M to $9.1M. Net loss decreased 19% to $9.5M. Revenues reflect Collaborative development services increase from $2.2M to $5.3M Product and product-related services increase from $948K to $3.8M. Lower net loss reflects Interest expense decrease of 44% to $416K (expense) Interest income increase from $30K to $331K (income). |
HTGMのテクニカル分析
HTGMのニュース
US Stocks Mixed; Housing Starts Edge Lower In March 2023/04/18 13:57:08 Benzinga
U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping over 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.12% to 33,945.01 while the NASDAQ rose 0.55% to 12,224.15. The S&P 500, also rose, gaining, 0.37% to 4,166.85. Check This Out: Apple, Zoom Video And 2 Other Stocks Insiders Are Selling Leading and Lagging Sectors Information technology shares rose by 0.9% on Tuesday. Meanwhile, top gainers in the sector included TeraWulf Inc. (NASDAQ: WULF ), up 8%, and inTEST Corporation (NYSE: INTT ), up 13%. In trading on Tuesday, health care fell by 0.3%. Top Headline Housing starts in the US fell 0.8% month-over-month to an annualized rate of 1.42 million in March, while building permits dipped 8.8% to an annual rate of 1.413 million. Equities Trading UP BELLUS Health Inc. (NASDAQ: BLU ) shares shot up 99% to $14.43 after GSK announced it will acquire the company for $14.75 per share in cash, representing an approximate total equity value of $2 billion.
HTG Announces Key First Quarter Milestone Achievements for Drug Discovery 2023/04/18 12:00:00 HTG Molecular Diagnostics
TUCSON, Ariz. , April 18, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today announced the achievement of three significant drug discovery business milestones in the first quarter of 2023.
H.C. Wainwright maintains HTG Molecular Diagnostics at Buy 2023/04/03 12:14:37 Investing.com
https://www.investing.com/news/pro/htg-molecular-diagnostics-receives-investment-bank-analyst-rating-update-3047641
Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday''s Mid-Day Session 2023/03/23 17:11:21 Benzinga
Gainers DiamondHead Holdings Corp. (NASDAQ: DHHC ) shares jumped 104.2% to $21.15. DiamondHead entered into convertible note purchase agreement dated March 21, 2023. Boxed, Inc. (NYSE: BOXD ) gained 59.1% to $0.2862 after gaining around 50% on Wednesday. Boxed recently said it is evaluating potentially filing for relief under the U.S. Bankruptcy Code and other strategic alternatives. ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA ) shares climbed 36.8% to $2.16. ZyVersa Therapeutics recently reported new employment inducement grants under Nasdaq Listing Rule 5635(c)(4). CXApp Inc. (NASDAQ: CXAI ) climbed 29.4% to $2.20. Generation Bio Co. (NASDAQ: GBIO ) gained 27% to $4.9299. SMX (Security Matters) Public Limited Company (NYSE: SMX ) gained 26.4% to $1.2016. KludeIn I Acquisition Corp. (NASDAQ: INKA ) rose 26.3% to $12.63. BM Technologies, Inc. (NASDAQ: BMTX ) shares gained 25.5% to $3.35. BM Technologies secured new bank partner and extended key partnerships. ERYTECH Pharma S.A. (NASDAQ: ERYP ) climbed 24.7% to $0.9878.
Was anything positive for HTG Molecular Diagnostics Inc. (HTGM) stock last session? 2023/01/25 12:00:00 US Post News
HTG Molecular Diagnostics Inc. (NASDAQ:HTGM) marked $4.42 per share on Tuesday, up from a previous closing price of $3.94. While HTG Molecular Diagnostics Inc. has overperformed by 12.18%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, HTGM fell by -89.51%, with highs and lows ranging from […]
HTG Molecular Diagnostics expects FY22 revenue above consensus 2023/01/06 13:38:02 Seeking Alpha
HTG Molecular Diagnostics (HTGM) expects FY22 total revenue to be ~$6.4M, including ~$2.7M of HTG Transcriptome Panel (HTP) revenue representing 42% of the total revenue.Consensus…
Peering Into HTG Molecular Diagnostics''s Recent Short Interest 2022/12/29 15:07:16 Benzinga
HTG Molecular Diagnostics''s (NASDAQ: HTGM ) short percent of float has risen 7955.56% since its last report. The company recently reported that it has 267 thousand shares sold short , which is 29.0% of all regular shares that are available for trading. Based on its trading volume, it would take traders 0.6 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of … Full story available on Benzinga.com
Kala, Cosmos top healthcare gainers; Minerva, HTG Molecular among losers 2022/12/28 15:00:16 Seeking Alpha
Kala Pharmaceuticals (KALA) +116%. Cosmos (COSM) +20%. Minerva Neurosciences NERV -16%. HTG Molecular Diagnostics (HTGM) -10%.
HTG Molecular Diagnostics Blasts Up after Public Offering Close 2022/12/27 19:41:32 TipRanks
From Beanie Babies to rare coins, scarcity has often meant greater value. HTG Molecular Diagnostics (NASDAQ:HTGM) provided one more example of just…
EH, PR and WE among mid-day gainers and losers 2022/12/27 17:39:38 Seeking Alpha
Gainers:180 Life Sciences Corp. (ATNF) +69%.HTG Molecular Diagnostics, Inc
HTG Molecular Diagnostics Reports Third Quarter 2022 Results 2022/11/10 21:05:00 GlobeNewswire
TUCSON, Ariz., Nov. 10, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, today reported financial results for the quarter ended September 30, 2022 and provided recent business highlights.
HTG Provides Update on Third Quarter Progress Toward Its Transcriptome-Informed Approach to Drug Discovery 2022/10/12 20:05:00 GlobeNewswire
TUCSON, Ariz., Oct. 12, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, completed its planned milestones for the third quarter of 2022, further advancing its transcriptome-informed approach to drug design and discovery utilizing the company’s proprietary HTG EdgeSeq technology.
HTG Molecular Diagnostics (HTGM) Investor Presentation - Slideshow (NASDAQ:HTGM) 2022/09/16 19:37:33 Seeking Alpha
The following slide deck was published by HTG Molecular Diagnostics, Inc.
Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday 2022/09/16 08:38:59 Benzinga
Gainers HeartBeam, Inc. (NASDAQ: BEAT ) shares jumped 85.6% to close at $2.32 on Thursday after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO. NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO ) rose 47.2% to close at $24.82 after the company announced Dong-A has licensed its global exclusive development rights of DA-1241 for type 2 diabetes and non-alcoholic fatty hepatitis and DA-1726 for obesity and non-alcoholic fatty hepatitis to NeuroBo. Nabriva Therapeutics plc (NASDAQ: NBRV ) climbed 39.4% to close at $0.2671 after the company announced it will effect a 1-for-25 reverse stock split of its outstanding ordinary shares, which will be effective on September 16, 2022. ZW Data Action Technologies Inc. (NASDAQ: CNET ) gained 37.4% to close at $0.91. ZW Data Action Technologies reported planned acquisition of Henan Baodun. ZeroFox Holdings, Inc. (NASDAQ: ZFOX ) gained 32.7% to close at $7.76.
Surprising stocks: Fastenal Company (NASDAQ:FAST -0.21%), HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM 4.05%) 2022/09/14 23:37:42 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Surprising stocks: Fastenal Company (NASDAQ:FAST -0.21%), HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM 4.05%) appeared first on Stocks Equity .